314
Views
0
CrossRef citations to date
0
Altmetric
Review

Molecular imaging of thyroid and parathyroid diseases

, , , & ORCID Icon
Pages 317-333 | Received 24 Mar 2024, Accepted 05 Jun 2024, Published online: 18 Jun 2024

Figures & data

Table 1. Gamma camera radionuclides.

Table 2. positron emission tomography radionuclides.

Figure 1. 99mTc-pertechnetate scan presentation of Graves’ disease (a), autonomously functioning thyroid nodules (b) and destructive thyroiditis (c).

Figure 1. 99mTc-pertechnetate scan presentation of Graves’ disease (a), autonomously functioning thyroid nodules (b) and destructive thyroiditis (c).

Figure 2. 99mTc-pertechnetate (a) and 99mTc-MIBI (b) scans: cold and MIBI active nodules in both lobes (arrows). Histopathology: multifocal invasive follicular variant of papillary thyroid carcinoma.

Figure 2. 99mTc-pertechnetate (a) and 99mTc-MIBI (b) scans: cold and MIBI active nodules in both lobes (arrows). Histopathology: multifocal invasive follicular variant of papillary thyroid carcinoma.

Figure 3. 18FDG PET/CT (axial image): FDG-avid thyroid nodule (i.e. risk of malignancy about 30%).

Figure 3. 18FDG PET/CT (axial image): FDG-avid thyroid nodule (i.e. risk of malignancy about 30%).

Figure 4. Post-ablation131I SPECT/CT (B) in a young female affected by papillary thyroid carcinoma (pT2 Nx) showing a central neck lymph-node metastasis.

Figure 4. Post-ablation131I SPECT/CT (B) in a young female affected by papillary thyroid carcinoma (pT2 Nx) showing a central neck lymph-node metastasis.

Figure 5. Post-therapy131I WBS (a, anterior; b, posterior views) and SPECT/CT (C) in a 50 years old female affected by papillary thyroid carcinoma (pT2 N1b) showing multiple visceral and skeletal radioiodine-avid metastases.

Figure 5. Post-therapy131I WBS (a, anterior; b, posterior views) and SPECT/CT (C) in a 50 years old female affected by papillary thyroid carcinoma (pT2 N1b) showing multiple visceral and skeletal radioiodine-avid metastases.

Figure 6. 18F-FDG PET maximum intensity projection image of a patient with poorly differentiated thyroid carcinoma showing increasing radiopharmaceutical uptake within the thyroid, corresponding to the primary tumor site and multiple lymph node, lung, liver, bone and renal metastases.

Figure 6. 18F-FDG PET maximum intensity projection image of a patient with poorly differentiated thyroid carcinoma showing increasing radiopharmaceutical uptake within the thyroid, corresponding to the primary tumor site and multiple lymph node, lung, liver, bone and renal metastases.

Figure 7. Parathyroid ultrasound: ovoidal hypoechoic nodule with vascular basket-pole, consistent with enlarged and hyperfunctioning parathyroid gland.

Figure 7. Parathyroid ultrasound: ovoidal hypoechoic nodule with vascular basket-pole, consistent with enlarged and hyperfunctioning parathyroid gland.

Figure 8. 99mTc-MIBI dual phase scintigraphy: tracer uptake and late retention in a parathyroid adenoma (red arrow).

Figure 8. 99mTc-MIBI dual phase scintigraphy: tracer uptake and late retention in a parathyroid adenoma (red arrow).

Figure 9. 99mTc-MIBI SPECT/CT (coronal a-c, axial d-f): ectopic mediastinal parathyroid adenoma (red arrows).

Figure 9. 99mTc-MIBI SPECT/CT (coronal a-c, axial d-f): ectopic mediastinal parathyroid adenoma (red arrows).

Figure 10. 18F-fluorocholine PET/CT (axial a, coronal b): parathyroid adenoma (red arrows).

Figure 10. 18F-fluorocholine PET/CT (axial a, coronal b): parathyroid adenoma (red arrows).